Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of ExpreS2ion Biotechnologies.

    Client Virtual Booth

    EXPRES2ION BIOTECHNOLOGIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ExpreS2ion Biotechnologies
    Denmark Flag
    Country
    Country
    Denmark
    Address
    Address
    SCION-DTU Science Park Agern Allé 1 DK-2970 Horsholm Denmark
    Telephone
    Telephone
    +45 2222 1019
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://expres2ionbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/expres2ion-biotechnologies/
    Twitter
    Twitter
    https://twitter.com/expres2ionb?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Evaxion and ExpreS²ion Initiate Research Collaboration On A Novel Cytomegalovirus (CMV) Vaccine Candidate

    Details:

    Under the terms of the collaboration, ExpreS2ion will have the exclusive right to license the EVX-V1 (CMV vaccine candidate) under a potential development and commercialization agreement.


    Lead Product(s): EVX-V1

    Therapeutic Area: Infections and Infectious Diseases Product Name: EVX-V1

    Highest Development Status: PreclinicalProduct Type: Vaccine

    Recipient: Evaxion Biotech

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration December 06, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    ExpreS2ion announces EU grant award for the COVID-19 vaccine development programme

    Details:

    The aim of the grant is to support the consortium in development of a COVID-19 vaccine candidate, including performing a Phase I/IIa clinical trial.


    Lead Product(s): COVID-19 vaccine

    Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

    Highest Development Status: UndisclosedProduct Type: Vaccine

    Partner/Sponsor/Collaborator: The EU Horizon 2020 consortium

    Deal Size: $0.9 million Upfront Cash: Undisclosed

    Deal Type: Funding March 06, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search